Helen Heffernan
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 11
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 17
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria 13
- Endocrinology top 5%
- Enterobacteriaceae and Cronobacter Research 3
-
- Bacterial biofilms and quorum sensing 8
-
- Pneumonia and Respiratory Infections 5
-
- Bacterial Infections and Vaccines 5
-
- Salmonella and Campylobacter epidemiology 4
- Co-authors
- Graeme R. NimmoGérard LinaMark C. EnrightTimothy GreenlandNadia LiassineFrançois VandeneschJérôme ÉtienneMichèle Bes
- Journals
- PLoS ONE (1 paper)Clinical Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (3 papers)
- Partner nations
- New ZealandAustraliaUnited States
In The Last Decade
Helen Heffernan
41 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Clinical Biochemistry 938
- Infectious Diseases 1.7k
- Molecular Medicine 361
- Applied Microbiology and Biotechnology 105
- Endocrinology 160
Countries citing papers authored by Helen Heffernan
This map shows the geographic impact of Helen Heffernan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Heffernan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Heffernan more than expected).
Fields of papers citing papers by Helen Heffernan
This network shows the impact of papers produced by Helen Heffernan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Heffernan. The network helps show where Helen Heffernan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helen Heffernan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2019 | 5 | |
| 3 | 2018 | 20 | |
| 4 | 2018 | 25 | |
| 5 | 2015 | 7 | |
| 6 | 2014 | 55 | |
| 7 | 2014 | 1 | |
| 8 | 2013 | 46 | |
| 9 | 2012 | 12 | |
| 10 | 2012 | 83 | |
| 11 | 2011 | 14 | |
| 12 | 2011 | 13 | |
| 13 | 2011 | 11 | |
| 14 | 2009 | 33 | |
| 15 | 2008 | 48 | |
| 16 | 2008 | 37 | |
| 17 | 2007 | 12 | |
| 18 | 1991 | 22 | |
| 19 | 1989 | 29 | |
| 20 | 1957 | 1 |
About Helen Heffernan
Helen Heffernan is a scholar working on Molecular Medicine, Clinical Biochemistry and Endocrinology, having authored 43 papers that have together received 2.3k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (17 papers), Antibiotic Resistance in Bacteria (13 papers), Bacterial Identification and Susceptibility Testing (11 papers), Bacterial biofilms and quorum sensing (8 papers), Pneumonia and Respiratory Infections (5 papers), Bacterial Infections and Vaccines (5 papers), Salmonella and Campylobacter epidemiology (4 papers) and Enterobacteriaceae and Cronobacter Research (3 papers). The work is most often cited by research in Clinical Biochemistry (938 citations), Infectious Diseases (1.7k citations) and Molecular Medicine (361 citations). Helen Heffernan has collaborated with scholars based in New Zealand, Australia and United States. Frequent co-authors include Graeme R. Nimmo, Gérard Lina, Mark C. Enright, Timothy Greenland, Nadia Liassine, François Vandenesch, Jérôme Étienne, Michèle Bes, M.E. Reverdy and Timothy S. Naimi. Their work appears in journals such as PLoS ONE, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.